Tepezza hearing loss and other Tepezza hearing problems have been reported by medical doctors and patients since this treatment for Thyroid Eye Disease was approved by the FDA in 2020. Those Tepezza hearing problems have involved various medical diagnosis types, including: Hypoacusis: hearing … More
Main Navigation Menu
➤ Current Drug Injury Lawsuits / Pharmaceutical Litigations
➤ Case Evaluations — Free. Confidential. No Obligation.
➤ Information About Law Offices of Thomas J. Lamb
➤ Questions New Clients Have Asked Us (FAQs)
➤ Patient Resources: Medical Sites and More
➤ Collection of Our “Side Effects” Blog Articles
Please know that you can use our Quick Contact Form to tell us about your case.
Recent News & Case Reports
FDA AdComm: Copiktra Risk-Benefit Profile No Longer Favorable as a Third-Line CLL/SLL Treatment
The FDA’s Oncologic Drugs Advisory Committee (ODAC) has voted 8-4 against the Copiktra risk-benefit profile, as reported in this September 23, 2022, Endpoint News article, "FDA adcomm takes down Secura Bio's leukemia drug after final trial results show potential OS detriment". From that recent … More
Gallbladder Side Effects Related to Byetta and Other GLP-1 Receptor Agonists
Cases of gallbladder side effects related to Byetta, Trulicity, Ozempic, and Adlyxin were reported in this August 2022 medical journal JAMA Internal Medicine article, "Acute cholecystitis associated with the use of glucagon-like peptide-1 receptor agonists reported to the US Food and Drug … More
Off-Topic Alert: Breast Implants Lymphoma Cancer Diagnosed More Often as Time Goes On
There is some new medical research about current population-based estimates of the incidence of breast implants-associated anaplastic large cell lymphoma (BIA-ALCL) — more commonly called breast implants lymphoma cancer — in the US, and the findings are rather alarming. From this recent news … More
Copiktra May Increase Risks of Death and Serious Side Effects
From this June 30, 2022, FDA Drug Safety Communication, "FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)", we get the following: To evaluate the long-term safety of Copiktra, we required the drug manufacturer, Secura Bio, to submit the … More
Xalkori Side Effects: Children Suffering Ocular Toxicity and Severe Visual Loss
A June 14, 2022, European Pharmaceutical Review (EPR) article about the most recent meeting of EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) reports a new drug safety issue involving Xalkori-related vision disorders found in clinical trials for pediatric patients treated with … More